You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TVTX Exercise Disclosure
Heerma Peter · SEC Form 4 · Filed Sep 17, 2026
Exercise
Calculated transaction value
$0
Heerma Peter EVP, Chief Commercial Officer
TVTX
Travere Therapeutics
TVTX
Transaction date
Sep 17, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed same day
TVTX daily price context
Close on/before transaction
$64.74
Sep 17, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee stock option (right to buy) on Common Stock
- Quantity / price
- 8,282 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001789617-26-000004
Filing cohort
Transactions in this filing
Showing 15 of 21
Trades
21
Issuers
1
Estimated value
$21.91M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Travere Therapeutics, Inc. TVTX Current | Exercise | Sep 17, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 17, 2026 | $538.92K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 17, 2026 | $185.52K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $850.3K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $476.23K |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 16, 2026 | $5.04M |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $1.13M |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 16, 2026 | $5.92M |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $30.93K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $1.06M |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $0 |